One of our missions is to develop new treatments for cancer. We currently have seven full-time and 10 part-time basic research faculty within the Division of Surgical Oncology working to develop novel therapies for cancer. This includes the development of biologic therapies (immunotherapy, gene therapy) for cancer. Other areas of active research seek new or better treatments for diverticulitis, pancreas dysfunction, and inflammatory bowel disease.
Many exciting advances in this field have come from within the division. The division is ideally structured to translate our basic research findings to the clinics. Our active clinical practices yield numerous instances where standard therapies are inadequate. In these cases patients are encouraged to consider clinical trials of novel therapies. You may be asked to participate in these trials during your appointments.
Translational research in the Division of Surgical Oncology is well supported by numerous grants from the National Institutes of Health (NIH) and the National Cancer Institute, as well as by a number of investigator-initiated grants from private foundations and industry.
For further information regarding individual research, please call 412-383-8603.